IGF1R and pancreatic neoplasm: Stalnecker et al. performed a CRISPR/Cas9 loss-of-function screen and found that IGF1R was the top sensitizer of pancreatic cancer cells to the autophagy-inducing agent hydroxychloroquine [26].